Biocept to Present at the 27th Annual ROTH Conference
March 03, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, March 3, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
Dr. David Rimm Joins Biocept, Inc. as a Scientific Advisor
March 02, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating...
Biocept, Inc. Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results
February 25, 2015 16:15 ET
|
Biocept, Inc.
SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating...
Study Highlights Value of Biocept's Blood-Based Diagnostic for Determining Hormonal Status in Patients With Metastatic Breast Cancer
February 23, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (ctDNA) and...
Biocept, Inc. Prices $10,000,000 Public Offering
February 09, 2015 18:21 ET
|
Biocept, Inc.
SAN DIEGO, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and circulating tumor...
Biocept Introduces New Test for Patients With Non-Small Cell Lung Cancer
January 20, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and Circulating...
Biocept Launches Selector(TM), a Blood Based Test for EGFR Mutations for Non-Small Cell Lung Cancer Patients
January 12, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and Circulating...
Biocept and Insight Genetics Collaborate to Advance Non-Small Cell Lung Cancer Diagnosis and Treatment
January 08, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO and NASHVILLE, Tenn., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor...
Biocept to Present at the 8th Annual OneMedForum
January 07, 2015 09:00 ET
|
Biocept, Inc.
SAN DIEGO, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network
January 07, 2015 08:30 ET
|
Biocept, Inc.
SAN DIEGO, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor cells (CTCs) and circulating...